Nightingale Health Plc will set up its UK laboratory in Porton Science Park in South Wiltshire. The company announced in January 2023 that it would open a laboratory in the United Kingdom to expand its commercial activities. The now-announced location for the laboratory has been awarded a UK Life Science Opportunity Zone status and is situated alongside established R&D institutions, including the Ministry of Defence'sDefence Science and Technology Laboratory (Dstl) and the UK Health Security Agency (UKHSA).

The premises provide opportunities for collaboration and the sharing and promotion of innovation, expertise, and research with businesses based in the science park. By making its proprietary blood analysis technology locally available in the United Kingdom, Nightingale Health aims to expand its business with the medical research industry and, eventually, the entire health ecosystem. Having a laboratory close to UK-based customers removes the necessity to transport blood samples to Finland, with sample handling, shipping, and analyses carried out domestically, enabling fast response times required in large-scale clinical use.

Nightingale Health expects the laboratory to be operational by the end of the calendar year 2023 and full-scale production capability to ramp up during the first quarter of 2024.